July 21, 2022

The Summer 2022 edition of Magnify, now online, features a look at the challenges of autoimmune neurologic testing, our experts in this area, and recent awards, and catches up with a former fellow.

July 20, 2022

ARUP medical directors and scientists will share their research and expertise in areas like lab stewardship, biochemical genetics, and neonatal drug testing at AACC’s 2022 annual meeting in Chicago.

July 18, 2022

Scientist Michael T. Pyne shares ARUP’s challenges and process of developing a next generation sequencing (NGS) test for HIV-1 antiretroviral drug resistance.

June 15, 2022

ARUP experts say that the VALID Act, which would require FDA approval of all lab-developed tests, would add administrative and financial burdens to an already safe and effective validation process.

June 7, 2022

ARUP experts are to give six talks and poster presentations at the flagship annual meeting of the American Society for Microbiology (ASM) in Washington, D.C.

May 23, 2022

Noninvasive prenatal testing (NIPT) provides critical information to expectant parents. ARUP has updated its test offerings to include the most sensitive and specific alternatives available.

May 20, 2022

Two members of the ARUP Healthcare Advisory Services team have built the basis for an open access database that could change the way researchers perform meta-analyses.

May 19, 2022

Society's growing and changing understanding of how race, ethnicity, or ancestry (REA) is experienced and interpreted is prompting many clinical labs to reexamine practices related to REA data.

May 6, 2022

ARUP study finds pharmacogenetic testing to evaluate drug-gene interactions improves patient outcomes and patients' confidence in overall care.